Discontinuation report PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Report ID | 165196 |
Drug Identification Number | 02401339 |
Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Common or Proper name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TAZOBACTAM PIPERACILLIN |
Strength(s) | 0.5G 4G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 4.5G |
ATC code | J01CR |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-07-21 |
Actual discontinuation date | |
Remaining supply date | 2022-07-21 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-07-21 | English | Compare |
v2 | 2022-07-21 | French | Compare |
Showing 1 to 2 of 2